A 0 1 0 1 O
baseline 2 10 2 10 B-treatment
CT 11 13 11 13 I-treatment
chest 14 19 14 19 I-treatment
/ 19 20 19 20 I-treatment
abdomen 20 27 20 27 I-treatment
/ 27 28 27 28 I-treatment
pelvis 28 34 28 34 I-treatment
and 35 38 35 38 I-treatment
bone 39 43 39 43 I-treatment
scan 44 48 44 48 I-treatment
or 49 51 49 51 O
PET 52 55 52 55 B-treatment
/ 55 56 55 56 I-treatment
CT 56 58 56 58 I-treatment

A 0 1 59 60 O
known 2 7 61 66 O
history 8 15 67 74 O
of 16 18 75 77 O
HIV 19 22 78 81 B-chronic_disease
seropositivity 23 37 82 96 O

ALT 0 3 97 100 B-clinical_variable
and 4 7 101 104 O
AST 8 11 105 108 B-clinical_variable
≤ 12 13 109 110 O
2.5x 14 18 111 115 B-upper_bound
ULN 19 22 116 119 I-upper_bound
( 23 24 120 121 O
≤ 24 25 121 122 O
5x 26 28 123 125 O
ULN 29 32 126 129 O
in 33 35 130 132 O
patients 36 44 133 141 O
with 45 49 142 146 O
liver 50 55 147 152 B-cancer
metastases 56 66 153 163 I-cancer
) 66 67 163 164 O

Adequate 0 8 165 173 O
bone 9 13 174 178 O
marrow 14 20 179 185 O
function 21 29 186 194 O
as 30 32 195 197 O
shown 33 38 198 203 O
by 39 41 204 206 O
: 41 42 206 207 O
ANC 43 46 208 211 B-clinical_variable
≥ 47 48 212 213 O
1.5 49 52 214 217 B-lower_bound
x 53 54 218 219 I-lower_bound
10 55 57 220 222 I-lower_bound
^ 57 58 222 223 I-lower_bound
9 58 59 223 224 I-lower_bound
/ 59 60 224 225 I-lower_bound
L 60 61 225 226 I-lower_bound
, 61 62 226 227 O
Platelets 63 72 228 237 B-clinical_variable
≥ 73 74 238 239 O
75 75 77 240 242 B-lower_bound
x 78 79 243 244 I-lower_bound
10 80 82 245 247 I-lower_bound
^ 82 83 247 248 I-lower_bound
9 83 84 248 249 I-lower_bound
/ 84 85 249 250 I-lower_bound
L 85 86 250 251 I-lower_bound
, 86 87 251 252 O
Hb 88 90 253 255 B-clinical_variable
> 91 92 256 257 O
9 92 93 257 258 B-lower_bound
g 94 95 259 260 I-lower_bound
/ 95 96 260 261 I-lower_bound
dL 96 98 261 263 I-lower_bound

Adequate 0 8 264 272 O
renal 9 14 273 278 O
function 15 23 279 287 O
: 23 24 287 288 O
serum 25 30 289 294 B-clinical_variable
creatinine 31 41 295 305 I-clinical_variable
≤ 42 43 306 307 O
1.5 44 47 308 311 B-upper_bound
x 48 49 312 313 I-upper_bound
ULN 50 53 314 317 I-upper_bound

Age 0 3 318 321 B-age
≥ 4 5 322 323 O
18 6 8 324 326 B-lower_bound
years 9 14 327 332 I-lower_bound

Co 0 2 333 335 O
- 2 3 335 336 O
administration 3 17 336 350 O
with 18 22 351 355 O
moderate 23 31 356 364 O
CYP3A4 32 38 365 371 B-treatment
inhibitors 39 49 372 382 I-treatment
( 50 51 383 384 O
e.g. 51 55 384 388 O
, 55 56 388 389 O
erythromycin 57 69 390 402 B-treatment
, 69 70 402 403 O
fluconazole 71 82 404 415 B-treatment
) 82 83 415 416 O
or 84 86 417 419 O
PgP 87 90 420 423 B-treatment
inhibitors 91 101 424 434 I-treatment
may 102 105 435 438 O
be 106 108 439 441 O
used 109 113 442 446 O
with 114 118 447 451 O
caution 119 126 452 459 O
and 127 130 460 463 O
everolimus 131 141 464 474 B-treatment
dosing 142 148 475 481 O
must 149 153 482 486 O
be 154 156 487 489 O
discussed 157 166 490 499 O
with 167 171 500 504 O
PI 172 174 505 507 O
at 175 177 508 510 O
the 178 181 511 514 O
time 182 186 515 519 O
of 187 189 520 522 O
enrollment 190 200 523 533 O

Co 0 2 534 536 O
- 2 3 536 537 O
administration 3 17 537 551 O
with 18 22 552 556 O
strong 23 29 557 563 B-treatment
inhibitors 30 40 564 574 I-treatment
of 41 43 575 577 I-treatment
CYP3A4 44 50 578 584 I-treatment
( 51 52 585 586 O
e.g. 52 56 586 590 O
, 56 57 590 591 O
ketoconazole 58 70 592 604 B-treatment
, 70 71 604 605 O
itraconazole 72 84 606 618 B-treatment
, 84 85 618 619 O
ritonavir 86 95 620 629 B-treatment
) 95 96 629 630 O
or 97 99 631 633 O
P 100 101 634 635 B-treatment
- 101 102 635 636 I-treatment
glycoprotein 102 114 636 648 I-treatment
( 115 116 649 650 I-treatment
PgP 116 119 650 653 I-treatment
) 119 120 653 654 I-treatment

Female 0 6 655 661 B-gender
patients 7 15 662 670 I-gender
who 16 19 671 674 O
are 20 23 675 678 O
pregnant 24 32 679 687 B-pregnancy
or 33 35 688 690 O
breast 36 42 691 697 O
feeding 43 50 698 705 O
, 50 51 705 706 O
or 52 54 707 709 O
adults 55 61 710 716 O
of 62 64 717 719 O
reproductive 65 77 720 732 O
potential 78 87 733 742 O
who 88 91 743 746 O
are 92 95 747 750 O
not 96 99 751 754 B-contraception_consent
using 100 105 755 760 I-contraception_consent
effective 106 115 761 770 I-contraception_consent
birth 116 121 771 776 I-contraception_consent
control 122 129 777 784 I-contraception_consent
methods 130 137 785 792 I-contraception_consent

HBV 0 3 793 796 B-treatment
DNA 4 7 797 800 I-treatment
and 8 11 801 804 I-treatment
HCV 12 15 805 808 I-treatment
RNA 16 19 809 812 I-treatment
PCR 20 23 813 816 I-treatment
testing 24 31 817 824 O
are 32 35 825 828 O
required 36 44 829 837 O
at 45 47 838 840 O
screening 48 57 841 850 O
for 58 61 851 854 O
all 62 65 855 858 O
patients 66 74 859 867 O
with 75 79 868 872 O
a 80 81 873 874 O
positive 82 90 875 883 O
medical 91 98 884 891 O
history 99 106 892 899 O
based 107 112 900 905 O
on 113 115 906 908 O
risk 116 120 909 913 O
factors 121 128 914 921 O
and/or 129 135 922 928 O
confirmation 136 148 929 941 O
of 149 151 942 944 O
prior 152 157 945 950 B-chronic_disease
HBV 158 161 951 954 I-chronic_disease
/ 161 162 954 955 I-chronic_disease
HCV 162 165 955 958 I-chronic_disease
infection 166 175 959 968 I-chronic_disease

Histologically 0 14 969 983 O
confirmed 15 24 984 993 O
triple 25 31 994 1000 B-cancer
negative 32 40 1001 1009 I-cancer
breast 41 47 1010 1016 I-cancer
cancer 48 54 1017 1023 I-cancer
( 55 56 1024 1025 O
ER 56 58 1025 1027 B-clinical_variable
< 58 59 1027 1028 O
10 60 62 1029 1031 B-upper_bound
% 62 63 1031 1032 I-upper_bound
, 63 64 1032 1033 O
PR 65 67 1034 1036 B-clinical_variable
< 68 69 1037 1038 O
10 70 72 1039 1041 O
% 72 73 1041 1042 O
, 73 74 1042 1043 O
Her2neu 75 82 1044 1051 B-clinical_variable
IHC 83 86 1052 1055 I-clinical_variable
0 87 88 1056 1057 O
or 89 91 1058 1060 O
1 92 93 1061 1062 O
or 94 96 1063 1065 O
FISH 97 101 1066 1070 B-clinical_variable
/ 101 102 1070 1071 I-clinical_variable
ISH 102 105 1071 1074 I-clinical_variable
negative 106 114 1075 1083 O
) 114 115 1083 1084 O

Impairment 0 10 1085 1095 B-chronic_disease
of 11 13 1096 1098 I-chronic_disease
gastrointestinal 14 30 1099 1115 I-chronic_disease
function 31 39 1116 1124 I-chronic_disease
or 40 42 1125 1127 O
gastrointestinal 43 59 1128 1144 B-chronic_disease
disease 60 67 1145 1152 I-chronic_disease
that 68 72 1153 1157 O
may 73 76 1158 1161 O
significantly 77 90 1162 1175 O
alter 91 96 1176 1181 O
the 97 100 1182 1185 O
absorption 101 111 1186 1196 O
of 112 114 1197 1199 O
Everolimus 115 125 1200 1210 B-treatment
( 126 127 1211 1212 O
e.g. 127 131 1212 1216 O
, 131 132 1216 1217 O
ulcerative 133 143 1218 1228 B-chronic_disease
disease 144 151 1229 1236 I-chronic_disease
, 151 152 1236 1237 O
uncontrolled 153 165 1238 1250 O
nausea 166 172 1251 1257 O
, 172 173 1257 1258 O
vomiting 174 182 1259 1267 O
, 182 183 1267 1268 O
diarrhea 184 192 1269 1277 B-chronic_disease
, 192 193 1277 1278 O
malabsorption 194 207 1279 1292 B-chronic_disease
syndrome 208 216 1293 1301 I-chronic_disease
or 217 219 1302 1304 O
small 220 225 1305 1310 B-treatment
bowel 226 231 1311 1316 I-treatment
resection 232 241 1317 1326 I-treatment
) 241 242 1326 1327 O

Leptomeningeal 0 14 1328 1342 B-cancer
metastases 15 25 1343 1353 I-cancer

Negative 0 8 1354 1362 B-pregnancy
serum 9 14 1363 1368 I-pregnancy
pregnancy 15 24 1369 1378 I-pregnancy
test 25 29 1379 1383 O
within 30 36 1384 1390 O
7 37 38 1391 1392 B-upper_bound
days 39 43 1393 1397 I-upper_bound
prior 44 49 1398 1403 I-upper_bound
to 50 52 1404 1406 O
starting 53 61 1407 1415 O
treatment 62 71 1416 1425 B-treatment

Other 0 5 1426 1431 O
malignancies 6 18 1432 1444 B-cancer
within 19 25 1445 1451 O
the 26 29 1452 1455 O
past 30 34 1456 1460 B-upper_bound
3 35 36 1461 1462 I-upper_bound
years 37 42 1463 1468 I-upper_bound

Patient 0 7 1469 1476 O
should 8 14 1477 1483 O
also 15 19 1484 1488 O
avoid 20 25 1489 1494 O
close 26 31 1495 1500 O
contact 32 39 1501 1508 O
with 40 44 1509 1513 O
others 45 51 1514 1520 O
who 52 55 1521 1524 O
have 56 60 1525 1529 O
received 61 69 1530 1538 O
live 70 74 1539 1543 B-treatment
attenuated 75 85 1544 1554 I-treatment
vaccines 86 94 1555 1563 I-treatment

Patients 0 8 1564 1572 O
currently 9 18 1573 1582 O
receiving 19 28 1583 1592 O
anticancer 29 39 1593 1603 B-treatment
therapies 40 49 1604 1613 I-treatment
or 50 52 1614 1616 O
who 53 56 1617 1620 O
have 57 61 1621 1625 O
received 62 70 1626 1634 O
anticancer 71 81 1635 1645 O
therapies 82 91 1646 1655 O
within 92 98 1656 1662 O
2 99 100 1663 1664 B-upper_bound
weeks 101 106 1665 1670 I-upper_bound
of 107 109 1671 1673 O
the 110 113 1674 1677 O
start 114 119 1678 1683 B-treatment
of 120 122 1684 1686 I-treatment
study 123 128 1687 1692 I-treatment
drug 129 133 1693 1697 I-treatment
( 134 135 1698 1699 O
including 135 144 1699 1708 O
chemotherapy 145 157 1709 1721 B-treatment
, 157 158 1721 1722 O
radiation 159 168 1723 1732 B-treatment
therapy 169 176 1733 1740 I-treatment
, 176 177 1740 1741 O
and 178 181 1742 1745 O
biologics 182 191 1746 1755 B-treatment
) 191 192 1755 1756 O

Patients 0 8 1757 1765 O
may 9 12 1766 1769 O
have 13 17 1770 1774 O
had 18 21 1775 1778 O
up 22 24 1779 1781 O
to 25 27 1782 1784 O
3 28 29 1785 1786 B-upper_bound
prior 30 35 1787 1792 B-treatment
regimens 36 44 1793 1801 I-treatment
for 45 48 1802 1805 O
metastatic 49 59 1806 1816 B-cancer
disease 60 67 1817 1824 I-cancer

Patients 0 8 1825 1833 O
receiving 9 18 1834 1843 O
chronic 19 26 1844 1851 B-treatment
, 26 27 1851 1852 I-treatment
systemic 28 36 1853 1861 I-treatment
treatment 37 46 1862 1871 I-treatment
with 47 51 1872 1876 I-treatment
corticosteroids 52 67 1877 1892 I-treatment
or 68 70 1893 1895 O
another 71 78 1896 1903 B-treatment
immunosuppressive 79 96 1904 1921 I-treatment
agent 97 102 1922 1927 I-treatment
, 102 103 1927 1928 O
except 104 110 1929 1935 O
corticosteroids 111 126 1936 1951 O
with 127 131 1952 1956 O
a 132 133 1957 1958 O
daily 134 139 1959 1964 O
dosage 140 146 1965 1971 O
equivalent 147 157 1972 1982 O
to 158 160 1983 1985 O
prednisone 161 171 1986 1996 B-treatment
≤ 172 173 1997 1998 O
20 174 176 1999 2001 B-upper_bound
mg 177 179 2002 2004 I-upper_bound

Patients 0 8 2005 2013 O
who 9 12 2014 2017 O
have 13 17 2018 2022 O
received 18 26 2023 2031 O
live 27 31 2032 2036 B-treatment
attenuated 32 42 2037 2047 I-treatment
vaccines 43 51 2048 2056 I-treatment
within 52 58 2057 2063 O
1 59 60 2064 2065 B-upper_bound
week 61 65 2066 2070 I-upper_bound
of 66 68 2071 2073 O
start 69 74 2074 2079 O
of 75 77 2080 2082 O
Everolimus 78 88 2083 2093 B-treatment
and 89 92 2094 2097 O
during 93 99 2098 2104 O
the 100 103 2105 2108 O
study 104 109 2109 2114 O

Patients 0 8 2115 2123 O
who 9 12 2124 2127 O
have 13 17 2128 2132 O
received 18 26 2133 2141 O
prior 27 32 2142 2147 B-treatment
treatment 33 42 2148 2157 I-treatment
with 43 47 2158 2162 I-treatment
an 48 50 2163 2165 I-treatment
mTOR 51 55 2166 2170 I-treatment
inhibitor 56 65 2171 2180 I-treatment
( 66 67 2181 2182 O
sirolimus 67 76 2182 2191 B-treatment
, 76 77 2191 2192 O
temsirolimus 78 90 2193 2205 B-treatment
, 90 91 2205 2206 O
everolimus 92 102 2207 2217 B-treatment
) 102 103 2217 2218 O

Patients 0 8 2219 2227 O
with 9 13 2228 2232 O
a 14 15 2233 2234 O
known 16 21 2235 2240 O
hypersensitivity 22 38 2241 2257 O
to 39 41 2258 2260 O
Everolimus 42 52 2261 2271 B-allergy_name
or 53 55 2272 2274 O
other 56 61 2275 2280 O
rapamycins 62 72 2281 2291 B-allergy_name
( 73 74 2292 2293 O
sirolimus 74 83 2293 2302 B-allergy_name
, 83 84 2302 2303 O
temsirolimus 85 97 2304 2316 B-allergy_name
) 97 98 2316 2317 O
or 99 101 2318 2320 O
to 102 104 2321 2323 O
its 105 108 2324 2327 O
excipients 109 119 2328 2338 O

Patients 0 8 2339 2347 O
with 9 13 2348 2352 O
a 14 15 2353 2354 O
known 16 21 2355 2360 O
hypersensitivity 22 38 2361 2377 O
to 39 41 2378 2380 O
carboplatin 42 53 2381 2392 B-allergy_name

Patients 0 8 2393 2401 O
with 9 13 2402 2406 O
an 14 16 2407 2409 O
active 17 23 2410 2416 O
, 23 24 2416 2417 O
bleeding 25 33 2418 2426 B-chronic_disease
diathesis 34 43 2427 2436 I-chronic_disease

Patients 0 8 2437 2445 O
, 8 9 2445 2446 O
who 10 13 2447 2450 O
have 14 18 2451 2455 O
had 19 22 2456 2459 O
a 23 24 2460 2461 O
major 25 30 2462 2467 B-treatment
surgery 31 38 2468 2475 I-treatment
or 39 41 2476 2478 O
significant 42 53 2479 2490 O
traumatic 54 63 2491 2500 B-chronic_disease
injury 64 70 2501 2507 I-chronic_disease
within 71 77 2508 2514 O
4 78 79 2515 2516 B-upper_bound
weeks 80 85 2517 2522 I-upper_bound
of 86 88 2523 2525 O
start 89 94 2526 2531 O
of 95 97 2532 2534 O
study 98 103 2535 2540 B-treatment
drug 104 108 2541 2545 I-treatment
, 108 109 2545 2546 O
patients 110 118 2547 2555 O
who 119 122 2556 2559 O
have 123 127 2560 2564 O
not 128 131 2565 2568 O
recovered 132 141 2569 2578 O
from 142 146 2579 2583 O
the 147 150 2584 2587 O
side 151 155 2588 2592 O
effects 156 163 2593 2600 O
of 164 166 2601 2603 O
any 167 170 2604 2607 O
major 171 176 2608 2613 O
surgery 177 184 2614 2621 O
( 185 186 2622 2623 O
defined 186 193 2623 2630 O
as 194 196 2631 2633 O
requiring 197 206 2634 2643 O
general 207 214 2644 2651 B-treatment
anesthesia 215 225 2652 2662 I-treatment
) 225 226 2662 2663 O
or 227 229 2664 2666 O
patients 230 238 2667 2675 O
that 239 243 2676 2680 O
may 244 247 2681 2684 O
require 248 255 2685 2692 O
major 256 261 2693 2698 O
surgery 262 269 2699 2706 O
during 270 276 2707 2713 O
the 277 280 2714 2717 O
course 281 287 2718 2724 O
of 288 290 2725 2727 O
the 291 294 2728 2731 O
study 295 300 2732 2737 O

Prior 0 5 2738 2743 B-treatment
carboplatin 6 17 2744 2755 I-treatment
allowed 18 25 2756 2763 O
provided 26 34 2764 2772 O
greater 35 42 2773 2780 O
than 43 47 2781 2785 O
12 48 50 2786 2788 B-lower_bound
mos 51 54 2789 2792 I-lower_bound
have 55 59 2793 2797 O
elapsed 60 67 2798 2805 O
since 68 73 2806 2811 O
last 74 78 2812 2816 O
dose 79 83 2817 2821 O
of 84 86 2822 2824 O
carboplatin 87 98 2825 2836 O

Prior 0 5 2837 2842 B-treatment
treatment 6 15 2843 2852 I-treatment
with 16 20 2853 2857 O
any 21 24 2858 2861 O
investigational 25 40 2862 2877 B-treatment
drug 41 45 2878 2882 I-treatment
within 46 52 2883 2889 O
the 53 56 2890 2893 O
preceding 57 66 2894 2903 B-upper_bound
2 67 68 2904 2905 I-upper_bound
weeks 69 74 2906 2911 I-upper_bound

Stable 0 6 2912 2918 O
brain 7 12 2919 2924 B-cancer
metastases 13 23 2925 2935 I-cancer
allowed 24 31 2936 2943 O
( 32 33 2944 2945 O
> 33 34 2945 2946 O
2 35 36 2947 2948 B-lower_bound
weeks 37 42 2949 2954 I-lower_bound
, 42 43 2954 2955 O
clinically 44 54 2956 2966 O
- 54 55 2966 2967 O
stable 55 61 2967 2973 O
post 62 66 2974 2978 B-treatment
treatment 67 76 2979 2988 I-treatment
with 77 81 2989 2993 I-treatment
surgery+/-radiation 82 101 2994 3013 I-treatment
or 102 104 3014 3016 O
radiation 105 114 3017 3026 B-treatment
alone 115 120 3027 3032 I-treatment
and 121 124 3033 3036 I-treatment
off 125 128 3037 3040 I-treatment
steroids 129 137 3041 3049 I-treatment
) 137 138 3049 3050 O

Symptomatic 0 11 3051 3062 O
congestive 12 22 3063 3073 B-chronic_disease
heart 23 28 3074 3079 I-chronic_disease
failure 29 36 3080 3087 I-chronic_disease
of 37 39 3088 3090 O
New 40 43 3091 3094 B-clinical_variable
York 44 48 3095 3099 I-clinical_variable
heart 49 54 3100 3105 I-clinical_variable
Association 55 66 3106 3117 I-clinical_variable
Class 67 72 3118 3123 I-clinical_variable
III 73 76 3124 3127 B-lower_bound
or 77 79 3128 3130 O
IV 80 82 3131 3133 B-upper_bound

Topical 0 7 3134 3141 B-treatment
or 8 10 3142 3144 O
inhaled 11 18 3145 3152 B-treatment
corticosteroids 19 34 3153 3168 I-treatment
are 35 38 3169 3172 O
allowed 39 46 3173 3180 O

Uncontrolled 0 12 3181 3193 O
brain 13 18 3194 3199 B-cancer
metastases 19 29 3200 3210 I-cancer

WHO 0 3 3211 3214 B-clinical_variable
performance 4 15 3215 3226 I-clinical_variable
status 16 22 3227 3233 I-clinical_variable
≤ 23 24 3234 3235 O
2 25 26 3236 3237 B-upper_bound

Women 0 5 3238 3243 B-gender
of 6 8 3244 3246 O
childbearing 9 21 3247 3259 O
potential 22 31 3260 3269 O
must 32 36 3270 3274 O
have 37 41 3275 3279 O
a 42 43 3280 3281 O
negative 44 52 3282 3290 B-pregnancy
urine 53 58 3291 3296 I-pregnancy
or 59 61 3297 3299 I-pregnancy
serum 62 67 3300 3305 I-pregnancy
pregnancy 68 77 3306 3315 I-pregnancy
test 78 82 3316 3320 O
within 83 89 3321 3327 O
7 90 91 3328 3329 B-upper_bound
days 92 96 3330 3334 I-upper_bound
prior 97 102 3335 3340 I-upper_bound
to 103 105 3341 3343 O
administration 106 120 3344 3358 O
of 121 123 3359 3361 O
Everolimus 124 134 3362 3372 B-treatment

Women 0 5 3373 3378 B-gender
with 6 10 3379 3383 O
metastatic 11 21 3384 3394 B-cancer
breast 22 28 3395 3401 I-cancer
cancer 29 35 3402 3408 I-cancer
( 36 37 3409 3410 O
measurable 37 47 3410 3420 O
or 48 50 3421 3423 O
evaluable 51 60 3424 3433 O
including 61 70 3434 3443 O
bone 71 75 3444 3448 B-cancer
metastases 76 86 3449 3459 I-cancer
only 87 91 3460 3464 O
) 91 92 3464 3465 O

active 0 6 3466 3472 B-chronic_disease
( 7 8 3473 3474 O
acute 8 13 3474 3479 B-chronic_disease
or 14 16 3480 3482 O
chronic 17 24 3483 3490 B-chronic_disease
) 24 25 3490 3491 O
or 26 28 3492 3494 O
uncontrolled 29 41 3495 3507 B-chronic_disease
severe 42 48 3508 3514 I-chronic_disease
infections 49 59 3515 3525 I-chronic_disease

adequately 0 10 3526 3536 O
treated 11 18 3537 3544 O
carcinoma 19 28 3545 3554 B-cancer
of 29 31 3555 3557 I-cancer
the 32 35 3558 3561 I-cancer
cervix 36 42 3562 3568 I-cancer
or 43 45 3569 3571 O
basal 46 51 3572 3577 B-cancer
or 52 54 3578 3580 O
squamous 55 63 3581 3589 B-cancer
cell 64 68 3590 3594 I-cancer
carcinomas 69 79 3595 3605 I-cancer
of 80 82 3606 3608 I-cancer
the 83 86 3609 3612 I-cancer
skin 87 91 3613 3617 I-cancer

liver 0 5 3618 3623 B-chronic_disease
disease 6 13 3624 3631 I-chronic_disease
such 14 18 3632 3636 O
as 19 21 3637 3639 O
cirrhosis 22 31 3640 3649 B-chronic_disease
, 31 32 3649 3650 O
chronic 33 40 3651 3658 B-chronic_disease
active 41 47 3659 3665 I-chronic_disease
hepatitis 48 57 3666 3675 I-chronic_disease
or 58 60 3676 3678 O
chronic 61 68 3679 3686 B-chronic_disease
persistent 69 79 3687 3697 I-chronic_disease
hepatitis 80 89 3698 3707 I-chronic_disease
Note 90 94 3708 3712 O
: 94 95 3712 3713 O
A 96 97 3714 3715 O
detailed 98 106 3716 3724 O
assessment 107 117 3725 3735 O
of 118 120 3736 3738 O
Hepatitis 121 130 3739 3748 B-chronic_disease
B 131 132 3749 3750 I-chronic_disease
/ 132 133 3750 3751 I-chronic_disease
C 133 134 3751 3752 I-chronic_disease
medical 135 142 3753 3760 O
history 143 150 3761 3768 O
and 151 154 3769 3772 O
risk 155 159 3773 3777 O
factors 160 167 3778 3785 O
must 168 172 3786 3790 O
be 173 175 3791 3793 O
done 176 180 3794 3798 O
at 181 183 3799 3801 O
screening 184 193 3802 3811 O
for 194 197 3812 3815 O
all 198 201 3816 3819 O
patients 202 210 3820 3828 O

patients 0 8 3829 3837 O
receiving 9 18 3838 3847 O
corticosteroids 19 34 3848 3863 B-treatment
must 35 39 3864 3868 O
have 40 44 3869 3873 O
been 45 49 3874 3878 O
on 50 52 3879 3881 O
a 53 54 3882 3883 O
stable 55 61 3884 3890 O
dosage 62 68 3891 3897 O
regimen 69 76 3898 3905 O
for 77 80 3906 3909 O
a 81 82 3910 3911 O
minimum 83 90 3912 3919 O
of 91 93 3920 3922 O
4 94 95 3923 3924 B-upper_bound
weeks 96 101 3925 3930 I-upper_bound
prior 102 107 3931 3936 I-upper_bound
to 108 110 3937 3939 O
the 111 114 3940 3943 O
first 115 120 3944 3949 B-treatment
treatment 121 130 3950 3959 I-treatment
with 131 135 3960 3964 I-treatment
Everolimus 136 146 3965 3975 I-treatment

serum 0 5 3976 3981 B-clinical_variable
bilirubin 6 15 3982 3991 I-clinical_variable
≤ 16 17 3992 3993 O
1.5 18 21 3994 3997 B-upper_bound
x 22 23 3998 3999 I-upper_bound
ULN 24 27 4000 4003 I-upper_bound

severely 0 8 4004 4012 O
impaired 9 17 4013 4021 O
lung 18 22 4022 4026 O
function 23 31 4027 4035 O
as 32 34 4036 4038 O
defined 35 42 4039 4046 O
as 43 45 4047 4049 O
spirometry 46 56 4050 4060 B-clinical_variable
and 57 60 4061 4064 O
DLCO 61 65 4065 4069 B-clinical_variable
that 66 70 4070 4074 O
is 71 73 4075 4077 O
50 74 76 4078 4080 O
% 76 77 4080 4081 O
of 78 80 4082 4084 O
the 81 84 4085 4088 O
normal 85 91 4089 4095 O
predicted 92 101 4096 4105 O
value 102 107 4106 4111 O
and/or 108 114 4112 4118 O
02 115 117 4119 4121 O
saturation 118 128 4122 4132 O
that 129 133 4133 4137 O
is 134 136 4138 4140 O
89 137 139 4141 4143 B-upper_bound
% 139 140 4143 4144 I-upper_bound
or 141 143 4145 4147 O
less 144 148 4148 4152 O
at 149 151 4153 4155 O
rest 152 156 4156 4160 O
on 157 159 4161 4163 O
room 160 164 4164 4168 O
air 165 168 4169 4172 O

uncontrolled 0 12 4173 4185 O
diabetes 13 21 4186 4194 B-chronic_disease
as 22 24 4195 4197 O
defined 25 32 4198 4205 O
by 33 35 4206 4208 O
fasting 36 43 4209 4216 B-clinical_variable
serum 44 49 4217 4222 I-clinical_variable
glucose 50 57 4223 4230 I-clinical_variable
> 58 59 4231 4232 O
1.5 59 62 4232 4235 B-lower_bound
x 63 64 4236 4237 I-lower_bound
ULN 65 68 4238 4241 I-lower_bound

unstable 0 8 4242 4250 B-chronic_disease
angina 9 15 4251 4257 I-chronic_disease
pectoris 16 24 4258 4266 O
, 24 25 4266 4267 O
symptomatic 26 37 4268 4279 O
congestive 38 48 4280 4290 B-chronic_disease
heart 49 54 4291 4296 I-chronic_disease
failure 55 62 4297 4304 I-chronic_disease
, 62 63 4304 4305 O
myocardial 64 74 4306 4316 B-chronic_disease
infarction 75 85 4317 4327 I-chronic_disease
within 86 92 4328 4334 O
6 93 94 4335 4336 B-upper_bound
months 95 101 4337 4343 I-upper_bound
of 102 104 4344 4346 O
start 105 110 4347 4352 O
of 111 113 4353 4355 O
study 114 119 4356 4361 B-treatment
drug 120 124 4362 4366 I-treatment
, 124 125 4366 4367 O
serious 126 133 4368 4375 O
uncontrolled 134 146 4376 4388 O
cardiac 147 154 4389 4396 B-chronic_disease
arrhythmia 155 165 4397 4407 I-chronic_disease
or 166 168 4408 4410 O
any 169 172 4411 4414 O
other 173 178 4415 4420 O
clinically 179 189 4421 4431 O
significant 190 201 4432 4443 O
cardiac 202 209 4444 4451 B-chronic_disease
disease 210 217 4452 4459 I-chronic_disease

